Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Shares Issued (2021 - 2024)

Kezar Life Sciences' Shares Issued history spans 4 years, with the latest figure at $56000.0 for Q2 2024.

  • For Q2 2024, Shares Issued fell 99.96% year-over-year to $56000.0; the TTM value through Sep 2025 reached $56000.0, down 99.96%, while the annual FY2024 figure was $103000.0, 83.86% down from the prior year.
  • Shares Issued for Q2 2024 was $56000.0 at Kezar Life Sciences, down from $131.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $131.7 million in Q4 2023 and bottomed at $43000.0 in Q3 2023.
  • The 4-year median for Shares Issued is $282000.0 (2021), against an average of $20.5 million.
  • The largest annual shift saw Shares Issued skyrocketed 31108.53% in 2023 before it plummeted 99.96% in 2024.
  • A 4-year view of Shares Issued shows it stood at $580000.0 in 2021, then dropped by 12.76% to $506000.0 in 2022, then soared by 25927.67% to $131.7 million in 2023, then tumbled by 99.96% to $56000.0 in 2024.
  • Per Business Quant, the three most recent readings for KZR's Shares Issued are $56000.0 (Q2 2024), $131.7 million (Q4 2023), and $43000.0 (Q3 2023).